Author name: R A

IN ORDER TO GAIN A COMPETITIVE EDGE, SERVICE PROVIDERS ARE EXPANDING THEIR EXISTING CAPABILITIES TO ENHANCE THEIR PORTFOLIO OF OFFERINGS

The primary purpose of this analysis was to develop a deeper understanding of the overall strength of the contract service providers involved in this field. It allows companies to compare their existing capabilities within their respective peer groups and identify ways to gain a competitive edge in the industry. In addition, this analysis can be […]

IN ORDER TO GAIN A COMPETITIVE EDGE, SERVICE PROVIDERS ARE EXPANDING THEIR EXISTING CAPABILITIES TO ENHANCE THEIR PORTFOLIO OF OFFERINGS Read More »

Presence Of More Than 110 Service Providers Of Inhaled And Intranasal Drug Products Demonstrates The Popularity Of Outsourcing Trend

During our research, we were able to capture more than 110 players, which claim to offer services related to inhaled and intranasal drug products.   Amongst the total players having capability to offer services of inhaled and intranasal drugs products, most of the players engaged in this domain are mid-sized firms. Of these, most of

Presence Of More Than 110 Service Providers Of Inhaled And Intranasal Drug Products Demonstrates The Popularity Of Outsourcing Trend Read More »

TELERADIOLOGY SERVICES – HAS CREATED THE NEED FOR REMOTE PATIENT DIAGNOSIS

The “Teleradiology Services Market, report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of teleradiology solutions in the diagnostic imaging industry, till 2030. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.   Teleradiology is a branch of telemedicine that uses

TELERADIOLOGY SERVICES – HAS CREATED THE NEED FOR REMOTE PATIENT DIAGNOSIS Read More »

With over 20 approved products and several under development, the Avastin® biosimilars market is projected to witness noteworthy growth

In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition from biosimilars, in the United States, Europe, Japan, and other nations where it is approved   Roots Analysis has announced the addition of the “Avastin® (Bevacizumab) Biosimilars – Pipeline Review and Partnerships”

With over 20 approved products and several under development, the Avastin® biosimilars market is projected to witness noteworthy growth Read More »

The outsourced cell therapy consumables market is projected to grow at a CAGR of 18% during 2021-2031, claims Roots Analysis

Amidst the COVID-19 pandemic, there has been an evident surge in the demand for high quality cell therapies intended for research and therapeutic purposes, presenting lucrative opportunities for consumable providers having capabilities for raw material production   London Roots Analysis has announced the addition of the “Cell Therapy Consumables Market, 2021 – 2031” report to

The outsourced cell therapy consumables market is projected to grow at a CAGR of 18% during 2021-2031, claims Roots Analysis Read More »

The DNA data storage market – Roots Analysis

Exponential increase in amount of digital data being generated, coupled to the limitations of conventional storage mediums, has created a need for sustainable storage options and DNA data storage has garnered significant interest as an alternative     London   Roots Analysis has announced the addition of DNA Data Storage Market, 2021-2035” report to its

The DNA data storage market – Roots Analysis Read More »

The contract manufacturing market for Pharmaceuticals in China – Roots Analysis

Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world   Roots Analysis is pleased to announce the publication of its recent study, titled, “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030.”

The contract manufacturing market for Pharmaceuticals in China – Roots Analysis Read More »

the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

Roots Analysis has done a detailed study on “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))”

the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis Read More »

The elastomeric closures market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%

Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential   Roots Analysis is pleased to announce the publication of its recent study, titled, “Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030.”   The report features

The elastomeric closures market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7% Read More »

The elastomeric closures market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%,

Roots Analysis has done a detailed study on Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 400+ page report, which features 185+ figures and 235+ tables, please visit this link   Key Market Insights The elastomeric

The elastomeric closures market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%, Read More »